Astera Labs (NASDAQ:ALAB) Stock Price Down 6.9% – What’s Next?

Shares of Astera Labs, Inc. (NASDAQ:ALAB) traded down 6.9% on Friday . The stock traded as low as $304.15 and last traded at $304.5240. Approximately 396,418 shares were traded during mid-day trading, a decline of 93% from the average session volume of 5,525,582 shares. The stock had previously closed at $326.97.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on ALAB shares. Northland Securities cut shares of Astera Labs from an “outperform” rating to a “market perform” rating in a report on Tuesday, May 26th. JPMorgan Chase & Co. increased their price target on shares of Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 6th. Morgan Stanley raised their price objective on shares of Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 6th. Royal Bank Of Canada lifted their price objective on shares of Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a research note on Wednesday, May 6th. Finally, UBS Group upped their target price on shares of Astera Labs from $205.00 to $400.00 and gave the company a “neutral” rating in a report on Monday, June 29th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $282.00.

Astera Labs Stock Down 8.5%

The stock has a fifty day moving average price of $357.77 and a 200-day moving average price of $225.19. The firm has a market cap of $51.28 billion, a price-to-earnings ratio of 204.35, a price-to-earnings-growth ratio of 3.83 and a beta of 3.66.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. During the same period last year, the company earned $0.33 earnings per share. The company’s revenue for the quarter was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, research analysts expect that Astera Labs, Inc. will post 1.86 earnings per share for the current year.

Insider Buying and Selling

In other news, COO Sanjay Gajendra sold 400,000 shares of the business’s stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the transaction, the chief operating officer directly owned 5,064,213 shares in the company, valued at $1,470,141,033.90. The trade was a 7.32% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of the stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the transaction, the director directly owned 75,688 shares of the company’s stock, valued at $26,882,106.96. This represents a 11.67% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 1,676,845 shares of company stock worth $444,928,806. 10.40% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Astera Labs

A number of institutional investors have recently added to or reduced their stakes in the business. Accel Wealth Management purchased a new position in shares of Astera Labs during the 2nd quarter worth approximately $317,000. Handelsbanken Fonder AB boosted its stake in shares of Astera Labs by 11.3% in the second quarter. Handelsbanken Fonder AB now owns 44,500 shares of the company’s stock valued at $21,494,000 after buying an additional 4,500 shares in the last quarter. Redhawk Wealth Advisors Inc. acquired a new position in Astera Labs during the second quarter worth $331,000. Wealthcare Advisory Partners LLC grew its holdings in Astera Labs by 0.9% during the second quarter. Wealthcare Advisory Partners LLC now owns 22,845 shares of the company’s stock worth $11,035,000 after acquiring an additional 201 shares during the period. Finally, Focus Financial Network Inc. purchased a new position in Astera Labs in the second quarter worth $711,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.